Su propiedad de oxidorreduccin y que disminuye la proliferacin celular en las lneas celulares de prstata, pncreas, hgado, colon, mesotelioma y neuroblastoma
Among available RCTs, only hematologic outcomes were assessed: no evidence exists to confirm the assumption that hematologic outcomes gained with adjuvant therapy share the same risk-benefit profile as those gained with ESA and iron therapy alone
Thus, megaloblastic anemia should not be treated with folic acid until the underlying cause has been determined (20)
This powerful multi-pathway approach supports dramatic weight reduction, improved glucose metabolism, increased energy expenditure, and reduced inflammation
Abbreviations The following abbreviations are used in this manuscript: Author Contributions Conceptualization, S.D